SPM Corporation (HOSE:SPM)
Vietnam · Delayed Price · Currency is VND 10,200
+260 (2.62%)
At close: Feb 5, 2026
SPM Corporation Revenue
In the year 2025, SPM Corporation had annual revenue of 253.96B VND, down -14.72%. SPM Corporation had revenue of 48.12B in the quarter ending December 31, 2025, a decrease of -34.22%.
Revenue
253.96B
Revenue Growth
-14.72%
P/S Ratio
0.55
Revenue / Employee
1.02B
Employees
250
Market Cap
140.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 253.96B | -43.82B | -14.72% |
| Dec 31, 2024 | 297.78B | -108.33B | -26.68% |
| Dec 31, 2023 | 406.10B | -293.53B | -41.95% |
| Dec 31, 2022 | 699.63B | -10.26B | -1.44% |
| Dec 31, 2021 | 709.89B | 99.90B | 16.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Domesco Medical Import - Export Joint-Stock | 2.08T |
| Vimedimex Medi-Pharma JSC | 1.17T |
| OPC Pharmaceutical JSC | 1.12T |
| Vidipha Central Pharmaceutical JSC | 950.89B |
| Ben Tre Pharmaceutical JSC | 860.40B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Central Pharmaceutical Joint Stock Company No3 | 438.01B |
| Mediplantex National Pharmaceutical JSC | 367.08B |